Press "Enter" to skip to content

Generic Humalog; 23andMe T2D Test; Menopause Ads Blocked

Eli Lilly said it would introduce a generic version of Humalog (insulin lispro injection 100 units/mL) with a 50% lower price tag.

23andMe is offering a new at-home saliva test to gauge risk for developing type 2 diabetes. (Everyday Health)

The novel endogenous Cushing’s treatment levoketoconazole (Recorlev) succeeded in a phase III extension showing positive long-term efficacy and a favorable benefit-risk profile, Strongbridge Biopharma announced.

One study found infertility may increase a woman’s chance of developing cancer by 18%, although this associated risk was higher for uterine and ovarian cancer. (Human Reproduction)

Facebook is blocking ads promoting women’s health products targeting menopausal women like lubricants, yet allowing ads targeting men for erectile dysfunction, CNBC reported.

Mice fed a high-fat diet including 2% green tea extract gained less weight and had less insulin resistance versus those on a control diet. (Journal of Nutritional Biochemistry)

Exposure to endocrine-disrupting chemicals — specifically phthalates and polychlorinated biphenyl 153 — hindered sperm quality in both humans and dogs. (Scientific Reports)

Cardiovascular screening in 45 middle schoolers found two cases of diabetes. About a third of the sample also had abnormal glucose or cholesterol levels. (Journal of Pediatrics)